Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Therapy Name||A-485 + JQ1|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|A-485||CBP/p300 inhibitor 11||A-485 is a selective histone acetyltransferase inhibitor of EP300 and CREBBP, which induces cellular senescence, and may result in decreased cell proliferation and inhibition of tumor growth (PMID: 28953875, PMID: 30266801, PMID: 32366905).|
|JQ1||JQ-1||BET Inhibitor (Pan) 32||JQ1 is a BET bromodomain inhibitor with greatest specificity towards BRD4, resulting in decreased Myc expression, increased cell death, reduced macrophage immunosuppression, and inhibition of tumor growth (PMID: 24231268, PMID: 31018997, PMID: 30906568, PMID: 32800944).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|